284 related articles for article (PubMed ID: 15386209)
1. [Powder inhalation systems].
Kohlhäufl M; Haidl P; Voshaar T; Häussinger K; Köhler D
Dtsch Med Wochenschr; 2004 Sep; 129(39):2048-52. PubMed ID: 15386209
[TBL] [Abstract][Full Text] [Related]
2. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
Geller DE
Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
[TBL] [Abstract][Full Text] [Related]
3. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
[TBL] [Abstract][Full Text] [Related]
4. Novolizer: how does it fit into inhalation therapy?
Magnussen H
Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
[TBL] [Abstract][Full Text] [Related]
5. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
Amirav I; Newhouse MT; Mansour Y
Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
[TBL] [Abstract][Full Text] [Related]
6. Importance of inhaler devices in the management of airway disease.
Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
[TBL] [Abstract][Full Text] [Related]
7. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
8. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert MP
Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
[TBL] [Abstract][Full Text] [Related]
9. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
[TBL] [Abstract][Full Text] [Related]
10. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
11. Dry powder inhalers: an overview.
Atkins PJ
Respir Care; 2005 Oct; 50(10):1304-12; discussion 1312. PubMed ID: 16185366
[TBL] [Abstract][Full Text] [Related]
12. [Easyhaler--ideal dry powder inhaler].
Andrzej E; Małgorzata BE
Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343
[TBL] [Abstract][Full Text] [Related]
13. Key issues in inhalation therapy in children.
Brand PL
Curr Med Res Opin; 2005; 21 Suppl 4():S27-32. PubMed ID: 16138942
[TBL] [Abstract][Full Text] [Related]
14. Novolizer: the new technology for the management of asthma therapy.
Köhler D
Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S11-6. PubMed ID: 12974537
[TBL] [Abstract][Full Text] [Related]
15. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD.
Schulte M; Osseiran K; Betz R; Wencker M; Brand P; Meyer T; Haidl P
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):321-8. PubMed ID: 18823257
[TBL] [Abstract][Full Text] [Related]
16. Aerosol therapy: the special needs of young children.
Janssens HM; Tiddens HA
Paediatr Respir Rev; 2006; 7 Suppl 1():S83-5. PubMed ID: 16798606
[TBL] [Abstract][Full Text] [Related]
17. Dry powder inhalers: which factors determine the frequency of handling errors?
Wieshammer S; Dreyhaupt J
Respiration; 2008; 75(1):18-25. PubMed ID: 17911976
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
[TBL] [Abstract][Full Text] [Related]
19. A review of the development of Respimat Soft Mist Inhaler.
Dalby R; Spallek M; Voshaar T
Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
[TBL] [Abstract][Full Text] [Related]
20. In-vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates.
Feddah MR; Brown KF; Gipps EM; Davies NM
J Pharm Pharm Sci; 2000; 3(3):318-24. PubMed ID: 11177650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
